Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals

Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals

Breast cancer is the cancer with the most incidence and mortality in women. microRNAs are emerging as novel prognosis/diagnostic tools. Our aim was to identify a serum microRNA signature useful to predict cancer development. We focused on studying the expression levels of 30 microRNAs in the serum o...

Full description

Bibliographic Details
Main Authors: Andrea Feliciano, Lucila González, Yoelsis Garcia-Mayea, Cristina Mir, Mireia Artola, Nieves Barragán, Remedios Martín, Anna Altés, Josep Castellvi, Sergi Benavente, Santiago Ramón y Cajal, Martín Espinosa-Bravo, Javier Cortés, Isabel T. Rubio, Matilde E. LLeonart
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Oncology
Subjects:
breast cancer
serum
microRNAs
prognosis
diagnosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.586268/full

Similar Items

Similar Items